UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

Therapeutic Advances in Endocrinology and Metabolism, 2022, Vol.13, p.204201882211124-20420188221112490

2022

Volltextzugriff (PDF)

Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?

Therapeutic advances in endocrinology and metabolism, 2020, Vol.11, p.204201882092882-2042018820928824

2020

Volltextzugriff (PDF)

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

Scientific reports, 2021-05, Vol.11 (1), p.10624-10624, Article 10624

2021

Volltextzugriff (PDF)

Current and future therapies for type 1 diabetes

Diabetologia, 2021-05, Vol.64 (5), p.1037-1048

2021

Volltextzugriff (PDF)

Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer

Current pharmaceutical design, 2017-01, Vol.23 (25), p.3699

2017

Volltextzugriff (PDF)

Glucagon‐like peptide‐1 receptor agonists to expand the healthy lifespan: Current and future potentials

Aging cell, 2023-05, Vol.22 (5), p.e13818-n/a

2023

Volltextzugriff (PDF)

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study

PloS one, 2018-04, Vol.13 (4), p.e0196634-e0196634

2018

Volltextzugriff (PDF)

Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes

Cardiovascular diabetology, 2019-08, Vol.18 (1), p.114-114, Article 114

2019

Volltextzugriff (PDF)

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria

PloS one, 2021-03, Vol.16 (3), p.e0244402-e0244402

2021

Volltextzugriff (PDF)

The potential of glucagon-like peptide-1 receptor agonists in heart failure

Frontiers in physiology, 2022-09, Vol.13, p.983961-983961

2022

Volltextzugriff (PDF)

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria

PloS one, 2023-03, Vol.18 (3), p.e0283296-e0283296

2023

Volltextzugriff (PDF)

Editorial: Advanced Cardiovascular Imaging in Diabetes

Frontiers in endocrinology (Lausanne), 2022-03, Vol.13, p.848975

2022

Volltextzugriff (PDF)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Cardiovascular diabetology, 2017-07, Vol.16 (1), p.88-88, Article 88

2017

Volltextzugriff (PDF)

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials

Lipids in health and disease, 2023-09, Vol.22 (1), p.1-160, Article 160

2023

Volltextzugriff (PDF)

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria

Cardiovascular diabetology, 2018-04, Vol.17 (1), p.50-50, Article 50

2018

Volltextzugriff (PDF)

Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients

Acta diabetologica, 2018-11, Vol.55 (11), p.1143-1150

2018

Volltextzugriff (PDF)

Obesity-Related Kidney Disease: Current Understanding and Future Perspectives

Biomedicines, 2023-09, Vol.11 (9), p.2498

2023

Volltextzugriff (PDF)

The Effectiveness of Digital Health Lifestyle Interventions on People With Prediabetes: Protocol for a Systematic Review, Meta-Analysis, and Meta-Regression

JMIR research protocols, 2024-02, Vol.13, p.e50340-e50340

2024

Volltextzugriff (PDF)

The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls

Frontiers in endocrinology (Lausanne), 2021-12, Vol.12, p.780679-780679

2021

Volltextzugriff (PDF)

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

Frontiers in clinical diabetes and healthcare (online), 2022-03, Vol.3, p.856485-856485

2022

Volltextzugriff (PDF)

1.4: A Proteomic Marker of Diabetic Nephropathy is associated with Mortality in Patients with Type 2 Diabetes

Artery research, 2017-12, Vol.20 (1), p.48-48

2017

Volltextzugriff (PDF)

Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: A systematic review and meta‐analysis

Obesity reviews, 2021-01, Vol.22 (1), p.e13136-n/a

2021

Volltextzugriff (PDF)

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial

Circulation (New York, N.Y.), 2018-12, Vol.138 (25), p.2908-2918

2018

Volltextzugriff (PDF)

Global Changes in Food Supply and the Obesity Epidemic

Current obesity reports, 2016-12, Vol.5 (4), p.449-455

2016

Volltextzugriff (PDF)

FC 058THE IMPORTANCE OF ADDRESSING MULTIPLE RISK MARKERS IN TYPE 2 DIABETES: RESULTS FROM THE LEADER AND SUSTAIN 6 TRIALS

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(47)
Diabetes
(39)
Endocrinology & Metabolism
(33)
Humans
(32)
Type 2 Diabetes
(25)
Diabetes Mellitus
(22)
Female
(21)
Male
(21)
Middle Aged
(21)
Cardiovascular Disease
(20)
Aged
(18)
Cardiovascular Diseases
(18)
Risk Factors
(18)
Mortality
(14)
Biomarkers
(13)
Diabetes Mellitus, Type 2 - Complications
(13)
Glomerular Filtration Rate
(12)
Creatinine
(11)
Kidney Diseases
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

Current and future therapies for type 1 diabetes

Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer

Glucagon‐like peptide‐1 receptor agonists to expand the healthy lifespan: Current and future potentials

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study

Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria

The potential of glucagon-like peptide-1 receptor agonists in heart failure

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria

Editorial: Advanced Cardiovascular Imaging in Diabetes

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria

Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients

Obesity-Related Kidney Disease: Current Understanding and Future Perspectives

The Effectiveness of Digital Health Lifestyle Interventions on People With Prediabetes: Protocol for a Systematic Review, Meta-Analysis, and Meta-Regression

The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

1.4: A Proteomic Marker of Diabetic Nephropathy is associated with Mortality in Patients with Type 2 Diabetes

Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: A systematic review and meta‐analysis

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial

Global Changes in Food Supply and the Obesity Epidemic

FC 058THE IMPORTANCE OF ADDRESSING MULTIPLE RISK MARKERS IN TYPE 2 DIABETES: RESULTS FROM THE LEADER AND SUSTAIN 6 TRIALS

Suchergebnisse filtern